Dr. Paul D. Olivo, M.D., Ph.D., has been the Chief Scientific Officer of Apath, LLC since 2000 and served as its President. Dr. Olivo is an Entrepreneur-in-Residence at BioGenerator, where he previously served as a Senior Entrepreneur-in-Residence. He served as a Vice President of R&D at Apath, LLC and served as its President since 2000. Dr. Olivo led a successful effort to license Apath’s key hepatitis C virus patents to multiple diagnostic and pharmaceutical companies and led the development of a novel technology to develop antiviral drugs which was instrumental in the company’s receiving 18 federal grants totaling over $12 million from 1999 to 2007. He joined Apath in 1998. He served as a Senior Medical Director of Quidel Corporation. Prior to joining Quidel, Dr. Olivo served as a Senior Vice President of R&D at Diagnostic Hybrids, Inc., where he played a significant role in managing the company’s pipeline and intellectual property during the acquisition of Hybrids by Quidel Corporation in 2010. Dr. Olivo has 20 years experience in the biotechnology industry in key executive positions at both established and start-up companies. He also has over 25 years experience in molecular biology and virology. Dr. Olivo serves as Director at Common Place Holdings. He serves as a Member of Scientific Advisory Board at Kypha Inc. Dr. Olivo served as a Medical Chief Resident at University of Wisconsin since 1986. He joined the faculty at Washington University School of Medicine in 1989 in the Department of Internal Medicine, Division of Infectious Diseases. He serves as an Adjunct Professor of Washington University Medical School in St. Louis, Missouri in the Department of Molecular Microbiology. Dr. Olivo is the inventor of multiple U.S. and foreign patents and has extensive knowledge of the application of genetically engineered cells to medical diagnostics. Currently Dr. Olivo is focusing his efforts on working with institutions in the greater St. Louis area to promote startup companies in the life sciences. Dr. Olivo performed his postdoctoral training in molecular virology at the National Institute of Allergy and Infectious Diseases at the NIH. He was a postdoctoral fellow at the National Institutes of Health from 1986 to 1989 in the Laboratory of Viral Diseases in the laboratories of Dr. Bernard Moss and Dr. Mark Challberg. Dr. Olivo is a licensed physician and board-certified Internist. Dr. Olivo holds B.A. from the George Washington University in Washington, D.C. in Anthropology and his M.D. in 1981 and Ph.D. in Microbiology in 1982 from the University of Florida. He received his medical training in Internal Medicine at the University of Wisconsin.